Medtronic (NYSE:MDT) said today that it has received FDA approval for the Percept PC deep brain stimulation (DBS) system.
FDA approves Medtronic’s latest DBS
Posted on June 28, 2020
Categories: In the News
Medtronic (NYSE:MDT) said today that it has received FDA approval for the Percept PC deep brain stimulation (DBS) system.